Zenas BioPharma, Inc. (ZBIO) Total liabilities 2023–2025
Zenas BioPharma, Inc. (ZBIO) total liabilities at each fiscal year-end, per SEC filings.
$141.5MFY2025 · since FY2023: $43.8M → $141.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $141.5M | +146.0% |
| FY2024 | $57.5M | +31.3% |
| FY2023 | $43.8M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More ZBIO financial trends
ZBIO RevenueZBIO Net incomeZBIO Net marginZBIO Gross profitZBIO Gross marginZBIO Operating incomeZBIO Operating marginZBIO Operating cash flowZBIO Free cash flowZBIO Capital expendituresZBIO Return on equityZBIO Stock buybacksZBIO Dividends paidZBIO Total assetsZBIO Shareholders’ equityZBIO overview →